N-乙半氨酸 (NAC) 对oxLDL诱导的内皮功能障碍的保护作用
Chathuri K Marasinghe1, Indyaswan Tegar Suryaningtyas2,3, Won-Kyo Jung4
1Department of Food and Life Science, Pukyong National University, Busan 48513, Republic of Korea.
Journal of microbiology and biotechnology
|August 7, 2025
概括
N-乙半氨酸 (NAC) 通过减少氧化应激和炎症来防止氧化LDL诱导的内皮功能障碍. 这种抗氧化剂通过改善血管健康,显示出预防心血管疾病的潜力.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 心血管研究研究心血管研究
背景情况:
- N-乙半氨酸 (NAC) 是一种已知的抗氧化剂和谷氨前体,具有既定的自由基清除和抗炎性质.
- 虽然NAC在各种模型中减轻了氧化损伤,但其在内皮功能障碍中的具体作用不太清楚.
- 内皮功能障碍,通常与心血管疾病有关,涉及氧化应激和炎症.
研究的目的:
- 研究N-乙半氨酸 (NAC) 在抵消氧化低密度脂蛋白 (oxLDL) 诱导的内皮功能障碍方面的疗效.
- 评估NAC对氧化应激标志物,细胞亡,线粒体功能和内皮细胞中氧化 (NO) 生物可用性的影响.
- 确定NAC对关键内皮细胞基因表达的影响,这些基因参与炎症和脂质代谢.
主要方法:
- 人类静脉内皮细胞 (HUVECs) 用oxLDL进行治疗,以诱导内皮功能障碍.
- 应用了NAC治疗来评估其保护作用.
- 测量包括活性氧物种 (ROS) 水平,脂质过氧化,亡标志物,线粒体膜潜力 (MMP) 和NO生物可用性.
- 对eNOS,LOX-1,ICAM-1和VCAM-1进行了基因表达分析.
主要成果:
- 在暴露于oxLDL的HUVEC中,NAC治疗显著降低了ROS生成和脂质过氧化.
- NAC减弱了亡标记物和恢复了线粒体膜潜力 (MMP),改善了细胞活力.
- 治疗增强了NO的生物可用性,并使ENOS,LOX-1,ICAM-1和VCAM-1的表达正常化.
- 此外,NAC还可以防止内皮细胞内过度的胆固醇积累.
结论:
- N-乙半氨酸 (NAC) 通过减轻氧化应激,炎症和亡,有效地预防oxLDL诱导的内皮功能障碍.
- 通过包括增强的NO生物可用性和炎症基因表达的调节在内的机制,NAC可以改善内皮功能.
- 这些发现表明,NAC具有重要的治疗潜力,可以预防与内皮功能障碍和脂质失调相关的心血管疾病.
相关概念视频
Cholesterol: Significance and Regulation
2.1K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
2.1K
Coronary Artery Disease II: Pathophysiology
1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Atherosclerosis I: Introduction
2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741


